Aligos Therapeutics, Inc.

Ownership Transactions Reported by 16 Insiders

Symbol
ALGS on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
Location
One Corporate Dr., 2 Nd Floor, South San Francisco, CA

There are no Buy or Sell transactions made by insiders since 10/6/2024

Aligos Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Heather Preston Director Jun 25, 2025
Margarita Chavez Director Jun 25, 2025
Hardean Achneck Chief Medical Officer Oct 8, 2024
Peter Hirth Director Jun 25, 2025
Carole Nuechterlein Director Jun 25, 2025
Lesley Ann Calhoun Chief Operating Officer and Chief Financial Officer Jul 16, 2025
Matthew W. McClure Chief Medical Officer Mar 1, 2024
Roche Holding Ltd 10%+ Owner Oct 25, 2023
James Scopa Director Jun 25, 2025
Jack Nielsen Director Feb 27, 2024
Lawrence Blatt President and CEO, Director Jul 16, 2025
Bridget Martell Director Jun 25, 2025
Julian A. Symons Executive Vice President, Chief Scientific Officer Jul 16, 2025
Leonid Beigelman President, Director Mar 15, 2023
Lucinda Y. Quan Executive Vice President, Chief Business Officer and General Counsel Sep 8, 2023
Thomas Woiwode Director Jun 23, 2022

Recent Insider Transactions by Companies or Individuals for Aligos Therapeutics, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.